Companies are struggling to find and retain data analytics talent. Find out why there's a shortage of data analysts and what your business can do.

SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. (“the Company” or “Jade”), (Nasdaq: ...

SAN FRANCISCO and VANCOUVER, British Columbia, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Jade Biosciences, Inc. ('the Company” or 'Jade”), (Nasdaq: JBIO), a clinical-stage biotechnology company focused on ...

At Celosphere 2025 in Munich, the German telco demonstrated how combining process mining with predictive AI enabled proactive customer interventions - offering a practical blueprint for ...

Otovo AS Class A ( (DE:89K) ) has issued an announcement. Otovo has announced a live-streamed presentation by CEO Andreas Thorsheim on November 6, 2025, at 08:30 CET. This event is part of Otovo’s ...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit. Unfortunately, these high risk investments ...

Presented data underscore the potential of lasme-cel (UCART22) and eti-cel (UCART20x22) to improve outcomes in r/r B-ALL and r/r NHL:Lasme-cel in ...

An AI-powered platform can advance the processing speed of data from large multi-center clinical trials.

Allogene Therapeutics, Inc. downgraded to Hold after ALPHA3 trial setbacks. Review updated pipeline prospects and risks.

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...